USSTOCK.TODAY
Weekend. Closed
Log in Sign up

Onconetix Inc(ONCO) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

ONCO
ONCO
Onconetix Inc
At close Nov 13 at 4:00 PM ET (Korea 11/14 06:00)
$3.21
+0.18 ▲ +5.94%
Nov 13 at 7:39 PM ET (Korea 11/14 09:39)
$3.14
-0.07 ▼ -2.18%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -1991Insider Own ⓘ -Shs Outstand ⓘ 0.4MPerf Week ⓘ -53.81%
Market Cap ⓘ 0.00BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ -Perf Month ⓘ -41.42%
Enterprise Value ⓘ -0.00BPEG ⓘ -EPS next Q ⓘ -Inst Own ⓘ 9.41%Short Float ⓘ -Perf Quarter ⓘ -57.62%
Income ⓘ -0.01BP/S ⓘ 2.9EPS this Y ⓘ -Inst Trans ⓘ -Short Ratio ⓘ 0.24Perf Half Y ⓘ -91.42%
Sales ⓘ 0.00BP/B ⓘ 0.09EPS next 5Y ⓘ -ROA ⓘ -57.37%Short Interest ⓘ 0.10MPerf YTD ⓘ -99.59%
Book/sh ⓘ 35.5P/C ⓘ 0.32EPS past 3/5Y ⓘ 83.59% 52.21%ROE ⓘ -102.87%52W High ⓘ -99.8% ($1610.00)Perf Year ⓘ -99.74%
Cash/sh ⓘ 10.11P/FCF ⓘ -Sales past 3/5Y ⓘ -ROIC ⓘ -75.63%52W Low ⓘ 9.18% ($2.94)Perf 3Y ⓘ -100%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 99.22%Gross Margin ⓘ 80.4%Volatility(W/M) ⓘ 35.99% 22.86%Perf 5Y ⓘ -
Dividend TTM ⓘ -EV/Sales ⓘ -5.95Sales Y/Y TTM ⓘ -51.33%Oper. Margin ⓘ -1190.29%ATR (14) ⓘ 1.07Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 2.14EPS Q/Q ⓘ 99.46%Profit Margin ⓘ -1578.79%RSI (14) ⓘ 38.91Recom ⓘ -
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 2.21Sales Q/Q ⓘ -83.92%SMA20 ⓘ -31.95% ($4.72)Beta ⓘ 2.64Target Price ⓘ -
Payout ⓘ -Debt/Eq ⓘ 0.01Earnings ⓘ -SMA50 ⓘ -48.56% ($6.24)Rel Volume ⓘ 0.19Prev Close ⓘ $3.03
Employees ⓘ 8LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -SMA200 ⓘ -96.78% ($99.69)Avg Volume(3M) ⓘ 0.40MPrice ⓘ $3.21
IPO ⓘ 2022/2/18Option/Short ⓘ No/YesTrades ⓘ 774Volume ⓘ 75,012Change ⓘ 5.94%
Company
ONCO ONCOOnconetix Inc | NASD | Biotechnology Deep dive

A small biotechnology company that develops diagnostic and therapeutic solutions in men's health and oncology. It offers a prostate cancer risk assessment test and a treatment for benign prostatic hyperplasia (BPH), and is also expanding into pancreatic cancer diagnostic technologies.

Quote

Over the past 1 year, on the lower side

100% below its 1-year high.

Now $3.21
52w low$2.9452w high$1610.00
52W Range0%
Volume ⓘ 75,012

Traded less than usual. That is 19% of its average volume.

C
Overall · average, with some caution
We judged 5 of the 8 questions below. 2 need caution.
No data for growth, outlook, dividends, or not applicable.
Peer comparison Biotechnology

It ranks #576 of 598 in the industry

Based on market cap of $2M.

FAQ

FAQ

What kind of company is ONCO?

ONCO belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of ONCO?

The market cap of ONCO is approximately $2M, ranking 5,795 within its sector.

What is the 52-week high and low for ONCO?

ONCO has recorded a 52-week high of $1610.00 and a low of $2.94.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels